Research Article

Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil

Figure 1

Percent of survival in ischemia model in Mongolian gerbil, evaluating different doses of intranasal formulation of Neuro-EPO *( 𝑃 < 0 . 0 1 ); **( 𝑃 ,0.02) indicate significant difference in Kaplan Miller Test respect with vehicle ( 𝑛 = 3 5 per group).
607498.fig.001